ko pathway ratio_in_study ratio_in_pop p_value ko04621 NOD-like receptor signaling pathway 14/104 157/7206 4.44719641333e-08 ko04380 Osteoclast differentiation 12/104 134/7206 4.19861530628e-07 ko04060 Cytokine-cytokine receptor interaction 14/104 191/7206 5.15005712599e-07 ko04668 TNF signaling pathway 11/104 120/7206 1.04119808955e-06 ko04622 RIG-I-like receptor signaling pathway 8/104 62/7206 2.54779921331e-06 ko05161 Hepatitis B 12/104 173/7206 6.34922605204e-06 ko04210 Apoptosis 12/104 180/7206 9.54552495471e-06 ko05164 Influenza A 11/104 167/7206 2.57678240855e-05 ko04658 Th1 and Th2 cell differentiation 8/104 96/7206 6.66865056115e-05 ko04064 NF-kappa B signaling pathway 8/104 96/7206 6.66865056115e-05 ko04620 Toll-like receptor signaling pathway 8/104 100/7206 8.9242269621e-05 ko05142 Chagas disease (American trypanosomiasis) 9/104 130/7206 9.92216202183e-05 ko04657 IL-17 signaling pathway 7/104 87/7206 0.000241527574213 ko04662 B cell receptor signaling pathway 7/104 88/7206 0.000259328114478 ko04623 Cytosolic DNA-sensing pathway 5/104 41/7206 0.0002819607197 ko04931 Insulin resistance 8/104 137/7206 0.000772732211576 ko00643 Styrene degradation 2/104 4/7206 0.00121467570879 ko05152 Tuberculosis 9/104 187/7206 0.00144791299595 ko05160 Hepatitis C 8/104 153/7206 0.00158176485662 ko05162 Measles 7/104 120/7206 0.00166824399725 ko05167 Kaposi's sarcoma-associated herpesvirus infection 9/104 191/7206 0.0016772655829 ko05323 Rheumatoid arthritis 6/104 89/7206 0.00172549540764 ko04660 T cell receptor signaling pathway 7/104 124/7206 0.00201424145252 ko05145 Toxoplasmosis 7/104 126/7206 0.00220688885078 ko04630 Jak-STAT signaling pathway 7/104 132/7206 0.00287129555714 ko04217 Necroptosis 8/104 178/7206 0.0040567429526 ko05134 Legionellosis 5/104 74/7206 0.00416346356713 ko05168 Herpes simplex infection 8/104 182/7206 0.00463909890575 ko04932 Non-alcoholic fatty liver disease (NAFLD) 8/104 182/7206 0.00463909890575 ko05215 Prostate cancer 6/104 111/7206 0.00521346118431 ko04624 Toll and Imd signaling pathway 4/104 49/7206 0.00527177718523 ko05131 Shigellosis 5/104 82/7206 0.00644186836007 ko04930 Type II diabetes mellitus 4/104 54/7206 0.00744891583114 ko05321 Inflammatory bowel disease (IBD) 4/104 56/7206 0.0084636757031 ko04920 Adipocytokine signaling pathway 5/104 89/7206 0.00905505627507 ko00350 Tyrosine metabolism 3/104 33/7206 0.0116396295244 ko04974 Protein digestion and absorption 5/104 96/7206 0.0123233733419 ko04218 Cellular senescence 7/104 177/7206 0.0137989074026 ko05146 Amoebiasis 5/104 99/7206 0.0139415260358 ko04659 Th17 cell differentiation 5/104 106/7206 0.0182604493444 ko00140 Steroid hormone biosynthesis 3/104 41/7206 0.0209349311468 ko04976 Bile secretion 4/104 80/7206 0.0280654308667 ko00254 Aflatoxin biosynthesis 1/104 2/7206 0.0286585143892 ko04215 Apoptosis - multiple species 3/104 47/7206 0.0299363482092 ko05212 Pancreatic cancer 4/104 83/7206 0.0315676259715 ko04068 FoxO signaling pathway 6/104 167/7206 0.0333403835225 ko05220 Chronic myeloid leukemia 4/104 85/7206 0.0340392747418 ko04917 Prolactin signaling pathway 4/104 87/7206 0.0366210181097 ko05133 Pertussis 4/104 87/7206 0.0366210181097 ko05120 Epithelial cell signaling in Helicobacter pylori infection 4/104 92/7206 0.0435589818205 ko04933 AGE-RAGE signaling pathway in diabetic complications 5/104 135/7206 0.0451977839763